Correction to: British Journal of Cancer (2013) 109, 60–67. doi:10.1038/bjc.2013.226
Since the advance online publication of this paper in May 2013, the authors realised that fresh calculations of the cohort of testicular cancer patients were required after omitting nine patients who received radiotherapy. This resulted in slightly incorrect numbers presented in the data displayed in Tables 2, 4 and 5, and in sections of the Results.
In order to present the results correctly moving forward, the data have now been corrected in the paper which appears in this issue and are represented in the Tables following (see below).
Change history
09 July 2013
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2013.226
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Willemse, P., Burggraaf, J., Hamdy, N. et al. Erratum: Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer 109, 295–296 (2013). https://doi.org/10.1038/bjc.2013.358
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2013.358
